Information:
Fel:
ID
19265
Beskrivning
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00088478
Länk
https://clinicaltrials.gov/show/NCT00088478
Nyckelord
Versioner (1)
- 2016-12-16 2016-12-16 -
Uppladdad den
16 december 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Schizophrenia NCT00088478
Eligibility Schizophrenia NCT00088478
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00088478
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Schizophrenia | Psychotic episode
Item
patients must have schizophrenia and be experiencing a psychotic episode
boolean
C0036341 (UMLS CUI [1])
C0338614 (UMLS CUI [2])
C0338614 (UMLS CUI [2])
Comprehension Sufficient Protocol Compliance | Informed Consent
Item
each patient must have a level of understanding sufficient to complete all tests and examinations required by the protocol, and to provide informed consent
boolean
C0162340 (UMLS CUI [1,1])
C0205410 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2])
C0205410 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs | olanzapine
Item
patient must not have participated in a clinical trial of another investigational drug, including olanzapine, within 1 month (30 days) prior to the study entry
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
C0013230 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
female patients must not be pregnant or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Genderr Medical condition | Gender Medical condition Serious | Gender Medical condition Unstable | Schizophrenia
Item
female patients must not be experiencing acute, serious or unstable medical conditions other than schizophrenia
boolean
C0079399 (UMLS CUI [1,1])
C3843040 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C3843040 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C3843040 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
C0036341 (UMLS CUI [4])
C3843040 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C3843040 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C3843040 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
C0036341 (UMLS CUI [4])
olanzapine Therapeutic procedure Resistant to
Item
patients who were previously treated with olanzapine and are considered to be treatment-resistant to olanzapine, in the opinion of the investigator
boolean
C0171023 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
Seizures Quantity | Etiology Unresolved
Item
one or more seizures without a clear and resolved etiology is exclusionary. however, if the patient has had one or more seizures in the past with an identifiable etiology, and that etiology has been resolved, the patient may be entered.
boolean
C0036572 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1314792 (UMLS CUI [2,1])
C0443342 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C1314792 (UMLS CUI [2,1])
C0443342 (UMLS CUI [2,2])
Clozapine
Item
treatment with clozapine within 4 weeks prior to visit 1
boolean
C0009079 (UMLS CUI [1])
Substance Dependence | Nicotine Dependence | Caffeine dependence
Item
dsm-iv or dsm-iv-tr substance (except nicotine and caffeine) dependence within the past 30 days
boolean
C0038580 (UMLS CUI [1])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])
Remoxipride
Item
treatment with remoxipride within 6 months (180 days) prior to visit 1
boolean
C0073047 (UMLS CUI [1])